Key facts
- It has raised $7.0M; the latest was Accelerator/Incubator in Oct 2024.
- Notable investors include Google for Startups, 500 Global, MedTech Innovator, Microsoft for Startups, BEENEXT Capital Management — 18 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for Niramai
- ·The full record, as it builds
Funding rounds
No funding rounds for Niramai are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Niramai
Developer of a medical device designed to detect breast cancer at a much earlier stage than traditional methods or self-examination. The company's device uses an imaging method that is radiation-free, non-touch, and not painful, works for women of all ages, and employs artificial intelligence and machine learning algorithms, enabling healthcare practitioners to improve treatment outcomes and survival rates.
- Sector
- Healthcare
- HQ
- Bangalore, India
- Founded
- 2016
- Employees
- 72
- Website
- niramai.com/
- Ownership
- Privately Held (backing)
Niramai doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Niramai shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Niramai in its N-PORT filings yet. We sweep new filings monthly.